Therapeutic choices in persons with haemophilia at the time of COVID-19.

Coppola, Antonio; Riccardi, Federica; Tagliaferri, Annarita

Coppola, Antonio; Riccardi, Federica; Tagliaferri, Annarita.

Coppola A; Regional Reference Centre for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.
Riccardi F; Regional Reference Centre for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.
Tagliaferri A; Regional Reference Centre for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.

Blood Transfus ; 18(4): 326-327, 2020 07.

Article in English | MEDLINE | ID: covidwho-663261

Subject(s)

Betacoronavirus; Coronavirus Infections; Hemophilia A/therapy; Pandemics; Pneumonia, Viral; Antibodies, Bispecific/administration & dosage; Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19; Coronavirus Infections/prevention & control; Drug Substitution; Hemophilia A/complications; Hemorrhage/etiology; Hemorrhage/prevention & control; Hemorrhage/therapy; Humans; Injections, Subcutaneous; Office Visits; Pandemics/prevention & control; Patient Acceptance of Health Care; Patient Education as Topic; Pneumonia, Viral/prevention & control; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Hemophilia A Topics: Long Covid Limits: Humans Language: English Journal: Blood Transfus Year: 2020 Document Type: Article Affiliation country: 2020.0154-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google